news aktuell GmbH

nal von minden: Did my vaccine work? New rapid test for the determination of vaccination success.

25.5.2021 11:46:53 CEST | news aktuell GmbH | Press release

Share
Am I really protected against the coronavirus now? This is a question asked by many after receiving a vaccination. The medtech company nal von minden from Moers in Germany has now developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood. The NADAL® COVID-19 S1-NAb Test is now available all over Europe.

(Moers, Germany): “People want clarity once they been vaccinated against coronavirus: They want to know if it has worked“ says Thomas Zander, CEO of nal von minden GmbH. Depending on the particular vaccine used, the COVID-19 vaccines offer 70% or more protection from the disease – but not 100%.


If the vaccine has ‘worked’, the body produces human antibodies against the disease. “These antibodies ensure that, in the event of exposure, the disease pathogens – the coronaviruses – would be readily identified and quickly repelled. Rather like the police on alert.”

These antibodies can be found in human blood and, if present, are easily detectable. With the NADAL® COVID-19 S1-NAb Test, the process takes just a few minutes. Thomas Zander explains: “Our new rapid test for the detection of coronavirus antibodies can be carried out by your GP in the future, as the test is currently only for professional use. A tiny prick of the finger is enough. The little drop of blood is added to the accompanying test cassette, and results can be read within 15 minutes.”

The new rapid test has already been comprehensively studied in the USA and China. “In the USA and China the vaccination programmes are more progressed, so the first studies were carried out there,” says Zander. “Further quality studies at German research centres will follow shortly.” It has been confirmed that the antibody test works for all kinds of vaccines (BioNtech, AstraZeneca, Johnson&Johnson, Sinovac and Moderna).

Coronavirus vaccinations usually take place across two appointments, and the new rapid test can be carried out either two weeks after the first vaccination, or two weeks after the second, says Thomas Zander. “Those who produce an immune response following the first vaccine – which can cause, for example, mild cold-like symptoms – can first wait until after the second vaccination.” Of course, the test can also be carried out weeks or even months afterwards, as nobody yet knows how long the vaccinations protect us against coronaviruses.

Contacts

Gabriele Hellwig, info@hellwig-pr.de

Images

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Bikeleasing Group announces strategic investment in New Zealand’s leading bike leasing company Workride / Next strategic step in cross-continental expansion29.7.2026 14:18:02 CEST | Press release

The Bikeleasing Group announces strategic investment in Workride, New Zealand’s market leader for company bike leasing as an employee benefit. Around 2,000 New Zealand employers already use Workride’s offering. The investment extends the Bikeleasing Group’s international presence and marks its next cross-continental step in its growth trajectory.

Dr. Gunther von Hagens, Inventor of Plastination & Creator of BODY WORLDS, Has Passed Away27.7.2026 14:31:59 CEST | Press release

Heidelberg/Germany, July 27, 2026—It is with deep sadness that the family and the Institute for Plastination announce the passing of Dr. Gunther von Hagens, inventor of Plastination and creator of the BODY WORLDS exhibitions. He died on July 24, 2026, at the age of 81. Gunther von Hagens fundamentally transformed the field of anatomy. Through Plastination—the preservation techni­que he invented in 1977—he created an entirely new perspective of the human body for medical education, science and the general public. He made the complexity, vulnerability and beauty of the human body—previously reserved for the dissection room and anatomical textbooks –directly accessible to the wider public. Together with his wife and curator, Dr. Angelina Whalley, Gunther von Hagens created BODY WORLDS, one of the most successful exhibitions in the world. Since its debut, the exhibition has been visited by more than 58 million people. BODY WORLDS made anatomy publicly accessible, encouraged reflection on h

TOSYALI secured 187 million Euro financing from Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) for its first phase of 1.2 GW solar investment23.7.2026 15:25:09 CEST | Press release

TOSYALI continues to accelerate its energy transition by securing long term international financing for supporting its decarbonization agenda and sustainability investments. The company has signed Export Finance Buyer Credit Agreements worth 187 million euros with BBVA, under Spanish Export Credit Agency Cesce’s cover, for Osmaniye and Niğde Projects in its first phase of solar power plant (SPP) investments with total capacity of 1.2 GW.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye